Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
536 people get RMTI articles and Market Currents by email alert.
Get email alerts on RMTI »
FOCUS
|
PRO
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
-
-
-
-
Rockwell Medical: Q3 Expenses Jump, Calcitriol Launch Pushed Back AgainBrian Marckx • Mon, Nov 12, 2012 -
-
Rockwell Medical: SFP Is Key to Future Earnings PowerMike Havrilla • Thu, Jul 30, 2009
-
Update on Rockwell Medical's Phase 2b TrialMike Havrilla • Thu, Apr 30, 2009
-
-
Rockwell Medical: Poised to Emerge from Under the RadarMike Havrilla • Mon, Dec 31, 2007
-
Rockwell Medical's Roadmap to an Iron Therapy RevolutionGreg Ballard • Sun, Dec 30, 2007
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
Pharmaceutical And Biotechnology Insider Buys Last WeekGutone • Mon, Jul 2, 2012 -
-
-
-
Noteworthy Insider Buys And Sells In The Healthcare SectorGuruFundPicks • Fri, Jun 8, 2012 -
Bacterin and Rockwell Medical Join Russell IndexMobile Guru • Mon, Jun 13, 2011 -
-
2 Momentum Stocks and 1 ETF for Early SummerScott's Investments • Tue, May 31, 2011 -
Phase III Trials Could Be Explosive for Rockwell MedicalMobile Guru • Mon, May 9, 2011
-
BioMed News: Rockwell Medical, EXACT Sciences, MannKindMike Havrilla • Fri, Oct 30, 2009
-
Rockwell Medical's Potential for Exponential GainsMike Havrilla • Wed, Sep 2, 2009
-
-
Big Lineup of Healthcare Stocks Crack the Russell 3000 IndexM. E. Garza • Wed, Jul 1, 2009 -
-
-
-
-
Marketwire (Tue, 8:00AM)
-
Marketwire (May 29, 2013)
-
Marketwire (May 20, 2013)
-
Marketwire (May 20, 2013)
-
Marketwire (May 16, 2013)
-
GlobeNewswire (May 15, 2013)
-
at MarketWatch.com (May 14, 2013)
-
GlobeNewswire (May 8, 2013)
-
GlobeNewswire (May 8, 2013)
-
Marketwire (May 6, 2013)
-
Marketwire (May 3, 2013)
-
Marketwire (Apr 1, 2013)
-
GlobeNewswire (Mar 26, 2013)
-
GlobeNewswire (Mar 20, 2013)
-
GlobeNewswire (Mar 18, 2013)
-
Marketwire (Mar 8, 2013)
-
GlobeNewswire (Mar 7, 2013)
-
Marketwire (Jan 14, 2013)
-
Marketwire (Jan 7, 2013)
RMTI vs. ETF Alternatives
Company Description
Currently, there's no company description for RMTI.
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Wednesday, May 15, 10:49 AM Rockwell Medical (RMTI -3%) manages to claw back some of an earlier 9% hit in the premarket session, after the biopharma company priced its previously announced public offering of 11.475M shares at $3.05 - a whopping 15% discount from yesterday's close. The discount isn't too surprising when you take into consideration that the stock only has a float of around 26M shares. Net proceeds are expected to be used to fund SFP clinical trials and for other general corporate purposes. Comment! [Healthcare, On the Move]
-
Wednesday, May 15, 9:14 AM
Premarket gainers: CHCI +41%. DVR +25%. CLNT +14%. VIPS +13%. EJ +11%. AFFY +9%. CHLN +9%. SPWR +8%. AVEO +5%.
Losers: XONE -10%. RMTI -8%. WMC -5%. 2 Comments [On the Move] - Tuesday, May 14, 4:07 PM Rockwell Medical (RMTI) announces a public offering, and expects to grant the underwriters a 30-day option to purchase up to an additional 15% to cover over-allotments, if any. Size and terms of the offering weren't disclosed. Chardan Capital Markets, LLC is acting as the sole book-running manager for the offering. Shares -1.1% AH. Comment! [Healthcare, On the Move]
- Thursday, May 9, 3:30 AM Rockwell Medical (RMTI): Q1 EPS of -$0.72 misses by $0.24. Revenue of $12.34M misses by $0.73M. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Sunday, April 14, 10:48 PM The rest of the top 25 June deletions from the Russell 2000 expected by Credit Suisse: QUIK, IVAC, TINY, DSCO, RLOG, RMTI, AGEN, MSPD, DRL, AXTI, ELON, GYRO, CDZI, IQNT, BSCT, UAMY, MTSN, AUMN, URZ, INOD. ''IQNT is one of the more well-owned deletes among small cap funds," says CS. Comment! [Quick Ideas]
- Tuesday, March 19, 3:22 PM Rockwell Medical (RMTI -15%) gets pounded today, setting a 52-week low after reporting late yesterday that its Q4 loss per share widened to $0.66 from $0.48 as its bottom line was negatively impacted by higher clinical development expenses. Clinical development expense was $48.3 million compared to $17.8 million in. The company notes that sales rose 9% to $13M, but the result still came in slightly below the consensus forecasts of $13.04M. Comment! [Healthcare, Earnings, On the Move]
- Monday, March 18, 4:19 PM Rockwell Medical (RMTI): Q4 EPS of -$0.66 in-line. Revenue of $13M misses by $0.1M. Shares +0.2% AH. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Friday, March 8, 2:33 PM Rockwell Medical (RMTI +2.3%) gain today after the company signs a two-year contract with NxStage Medical (NXTM +1.8%) to manufacture dialysate concentrate for the NxStage System One. The device is the only portable hemodialysis system cleared for home use by the FDA. Comment! [Healthcare, On the Move]
- Monday, February 4, 9:22 AM Rockwell Medical (RMTI) +21.7% premarket on news its iron delivery drug met its targets in a late-stage trial, showing that treatment reduced the need for additional agents to boost red blood cell production by 37%. RMTI's lead drug, soluble ferric pyrophosphate, aims to treat iron deficiency in patients on hemodialysis. Comment! [Healthcare, On the Move]
-
Monday, February 4, 9:10 AM
Premarket gainers: APKT +23%. RMTI +22%. SONS +10%. PPHM +8%. CCUR +6%. GALE +6%.
Losers: HLF -9%. Comment! [On the Move] - Monday, January 7, 3:21 PM Rockwell Medical (RMTI +0.3%) says the final patient has been dosed in its PRIME clinical study, which is designed to investigate the reduction in the need for erythropoiesis stimulating agents in hemodialysis patients receiving Soluble Ferric Pyrophosphate. Soluble Ferric Pyrophosphate is RMTI's late-stage investigational drug currently in Phase 3 clinical study. Comment! [Healthcare]
-
Monday, December 17, 2012, 5:36 PM
After-hours top gainers, as of 5:15 p.m.: DFS +2.4%. TWO +2.3%. BAC +2.1%. UNIS +1.8%. RF +1.1%.
After-hours top losers: PHG -6%. RAS -5.5%. RMTI -3.4%. NWY -2.8%. UVXY -1.8%. Comment! [On the Move] - Tuesday, November 3, 2009, 11:11 AM Rockwell Medical Technologies (RMTI) down 3% after Sharesleuth.com publishes a report saying a key consultant faces SEC fraud charges. Shares were down as much as 10% premarket. Comment!
-
Ryan Mallory
Shining Prospects In My Long-Side Watch-List | $SLV $VFC $RMTI are at the top of the list. http://bit.ly/10U5fj0 - View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
Scott Matusow
One stock to consider as a short is Rockwell Medical ($RMTI) @Mcuban is short there, also this http://bit.ly/U5o0fi read carefully - View all 4 replies
-
-
-
freefdawatchlist
http://bit.ly/Le0Bda Premarket gainer IDIX(14%), TSLA(4%), STSI(4%), ARNA(4%), oser RMTI(6.5%), ADBE(6%), CETV(4%), ATPG(3%) - View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
LATEST REPLIES
-
Scott Matusow
One stock to consider as a short is Rockwell Medical ($RMTI) @Mcuban is short there, also this http://bit.ly/U5o0fi read carefully - View all 4 replies
-
-